41 results
8-K
EX-99.3
DAWN
Day One Biopharmaceuticals, Inc.
30 Jul 24
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
7:35am
) Sex, n (%) Male Female 40 (52) 37 (48) Race, n (%) White Asian Black Multiple Other Not specified 41 (53) 5 (6) 2 (3) 3 (4) 6 (8) 20 (26) Number
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals, Inc.
18 Jun 24
Entry into a Material Definitive Agreement
8:36am
) Cerebral hemisphere 8% Race, n (%) Cerebellum Brain stem White 41 (53) 6% 8% Asian 5 (6) Black 2 (3) Multiple 3 (4) Other 6 (8) BRAF alteration (n=77
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals, Inc.
12 Jun 24
Regulation FD Disclosure
8:07am
% 8% Asian 5 (6) Black 2 (3) Multiple 3 (4) Other 6 (8) BRAF alteration (n=77) Not specified 20 (26) Number of lines of prior systemic therapy 17
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals, Inc.
30 May 24
Day One Announces Sale of Priority Review Voucher for $108 Million
8:35am
% Asian 5 (6) Black 2 (3) Multiple 3 (4) Other 6 (8) BRAF alteration (n=77) Not specified 20 (26) Number of lines of prior systemic therapy 17% Median
8-K
EX-99.2
2n18ddzz10r1xhx
6 May 24
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.2
unj8ykhxfda7
24 Apr 24
Regulation FD Disclosure
8:01am
8-K
EX-99.1
6gmtvtihsf3r
24 Apr 24
Regulation FD Disclosure
8:01am
8-K
EX-99.2
a3glcqjc1i5qrqn3t7a
26 Feb 24
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.2
oayjx0f60z2jgi
8 Jan 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
opdv6oyprq
17 Nov 23
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
7:07am
8-K
EX-99.2
b6bklkfmn526oi0j
6 Nov 23
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
4:30pm
8-K
EX-99.2
8ktyvapmxi1iyeks
30 Oct 23
Regulation FD Disclosure
8:12am
8-K
EX-99.2
wpwf nn10a
11 Sep 23
Regulation FD Disclosure
8:35am
8-K
EX-99.2
j0mb1gtbk
16 Aug 23
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
8:06am
8-K
EX-99.2
tb54spgpr
7 Aug 23
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
4:30pm